β‐blockade prevents recurrent gastrointestinal bleeding in well‐compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial
Massimo Colombo, Roberto de Franchis, Maurizio Tommasini, Angelo Sangiovanni, Nicola Dioguardi – 1 March 1989 – To assess the efficacy of β‐blockers in preventing rebleeding in selected cirrhotic patients and to compare the tolerance, safety and patient compliance of a selective and a nonselective β‐blocker, 94 patients were randomly assigned to propranolol (32 patients), atenolol (32 patients) or placebo (30 patients). Randomization was made at least 15 days after the bleeding episode.